Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-60
SponsorPoznan University of Physical Education

About this trial

1 Recruitment. 2. Collection of written consents for the study. 3. Random assignment to groups with and without intervention. 4. Completion of questionnaires by study participants, postural pattern assessment, temporomandibular joint assessment, and platform assessment.

5\. Performance of visceral therapy in the group with intervention, in the group without intervention placebo. Duration 5 weeks, treatment 1x per week at the same time of day and given day e.g. Mondays only.

6\. Reassessment as in step 4. 7. Data collection, statistical analyses. 8. Interpretation of results for female participants. 9. Preparation of results for scientific publications.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Written consent to participate in the study.

Female patients after surgical treatment with prolapse of reproductive organs and diagnosed endometriosis.

Disqualifiers

No written consent to participate in the study.

Cancer.

Injury to the temporomandibular joint and pelvis.

Fibromyalgia.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Visceral therapy

    Other intervention

    Visceral therapy will be performed manually by a physiotherapist, a detailed description of the techniques is above. Therapy will be in 2 subgroups with prolapse of the usual genitals and endometriosis.

  • Placebo

    Other intervention

    Placebo will be in 2 subgroups that will not have visceral therapy. The placebo will consist of the physiotherapist holding hands on the patient's pelvis.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: 2 subgroups with wisceral therapyExperimental treatment 1 intervention
Group B: 2 subgroups with placebo (without intervention)Placebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

NRS

Each patient will mark on the NRS scale the sensation of pain before the tests. Scale of 1-10, the higher the value the greater the pain experience.

Time frame
Time point one: before starting visceral therapy and placebo, 1 st week
2

platforms

Each patient will have a postural stability assessment prior to testing.No platform manufacturer provides standards. The platform is equipped with sensors - it collects the force of the feet and gives how the center of gravity is located, that is, the front-back, side-to-side tilts are given.

Time frame
Time point one: before starting visceral therapy and placebo,1 st week
3

postural pattern by Halla-Wernhama-Littlejohna

Before the test, each patient will have a postural pattern assessment. Evaluating the pattern of type 1 anterior tilt of the body, type 2 normal, type 3 posterior tilt.

Time frame
Time point one: before starting visceral therapy and placeb1 st weeko,
4

pelvic type assessment

Before the test, each patient will have a pelvic type assessment. High-assimilated type: hip plates above the L5 segment: overloaded type: hip plates below the L4 segment; normal type: hip plates at the level of the L4-L5 segment.

Time frame
Time point one: before starting visceral therapy and placebo,1 st week

Secondary outcomes

1

NRS

After 5 weeks, each patient will mark on the pain sensation scale. Scale of 1-10, the higher the value the greater the pain experience.

Time frame
Time point two: after visceral therapy and placebo, 5th week
2

platforms

After 5 weeks, each patient will have a postural stability assessment. No platform manufacturer provides standards. The platform is equipped with sensors - it collects the force of the feet and gives how the center of gravity is located, that is, the front-back, side-to-side tilts are given.

Time frame
Time point two: after visceral therapy and placebo, 5th week
3

postural pattern by Halla-Wernhama-Littlejohna

After 5 weeks, each patient will have a posture pattern assessment. Evaluating the pattern of type 1 anterior tilt of the body, type 2 normal, type 3 posterior tilt.

Time frame
Time point two: after visceral therapy and placebo, 5th week
4

pelvic type assessment

After 5 weeks, each patient will have a pelvic type assessment.High-assimilated type: hip plates above the L5 segment: overloaded type: hip plates below the L4 segment; normal type: hip plates at the level of the L4-L5 segment.

Time frame
Time point two: after visceral therapy and placebo,5 th week

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Poznan University of Physical Education

Lead sponsor

University of Life Science in Poznan

Collaborator